The effect of continuous subdermal levonorgestrel (Norplant) on carbohydrate metabolism
- 1 January 1992
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 166 (1) , 15-19
- https://doi.org/10.1016/0002-9378(92)91819-v
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Norplant: Subdermal implant system for long-term contraceptionAmerican Journal of Obstetrics and Gynecology, 1989
- Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT® implants or two covered rods (NORPLANT®-2)Contraception, 1987
- Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective studyFertility and Sterility, 1986
- Levonorgestrel plasma levels during continuous administration with different models of subdermal implantsContraception, 1983
- Metabolic effects of progesteroneAmerican Journal of Obstetrics and Gynecology, 1982
- Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1982
- Prospective Studies of Carbohydrate Metabolism in “Normal” Women Using Norgestrel for Eighteen MonthsFertility and Sterility, 1981
- Carbohydrate and Lipid Metabolic Studies Before and after One Year of Treatment with Ethynodiol Diacetate in “Normal” Women**Supported in part by grants from the National Institutes of Health and by Ford Foundation Grant 700-0338.Fertility and Sterility, 1976
- The effect of estrogens on carbohydrate metabolism: Glucose, insulin, and growth hormone studies on one hundred and seventy-one women ingesting Premarin, mestranol, and ethinyl estradiol for six monthsAmerican Journal of Obstetrics and Gynecology, 1972
- Management of the rheumatoid patientArthritis & Rheumatism, 1963